Lung Cancer
Data from Washington University Provide New Insights into Lung Cancer
Published in Cancer Weekly, February 28th, 2012
2012 FEB 28 -- According to the authors of recent research from St. Louis, Missouri, "We sought to compare the relative cost-effectiveness of surgical intervention and stereotactic body radiation therapy in high risk patients with clinical stage I lung cancer (non-small cell lung cancer). We compared patients chosen for surgical intervention or SBRT for clinical stage I non-small cell lung cancer."
"Propensity score matching was used to adjust estimated treatment hazard ratios for the confounding effects of age, comorbidity index, and clinical stage. We assumed that Medicare-allowable charges were $15,034 for surgical intervention and $13,964 for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-02-28)
More Articles from Cancer Weekly
- Lung Cancer
Data from Dartmouth School of Medicine Provide New Insights into Lung Cancer - Lymphoid Tissue
Data on Lymphoid Tissue Discussed by M.A. Korteweg and Colleagues - Otorhinolaryngology
Data on Otorhinolaryngology Discussed by Researchers at University Hospital - Pancreatic Cancer
Data on Pancreatic Cancer Discussed by Researchers at Nanjing Medical University - Psychooncology
Data on Psychooncology Detailed by Researchers at University of Washington - Medicinal Chemistry
Findings from Purdue University Advance Knowledge in Medicinal Chemistry - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
